|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-4-30
|
|
pubmed:abstractText |
Erythropoietin (Epo) is a growth factor whose synthesis mainly takes place in the kidney. Epo has been shown to support the growth not only of erythroid progenitor cells but also of certain other cell types. We attempted to establish whether Epo enhances the recovery from acute renal failure induced by cisplatin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
932-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11328897-Acute Kidney Injury,
pubmed-meshheading:11328897-Animals,
pubmed-meshheading:11328897-Antineoplastic Agents,
pubmed-meshheading:11328897-Cisplatin,
pubmed-meshheading:11328897-Diuresis,
pubmed-meshheading:11328897-Erythropoietin,
pubmed-meshheading:11328897-Glomerular Filtration Rate,
pubmed-meshheading:11328897-Kidney,
pubmed-meshheading:11328897-Male,
pubmed-meshheading:11328897-Rats,
pubmed-meshheading:11328897-Rats, Sprague-Dawley,
pubmed-meshheading:11328897-Urine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat.
|
|
pubmed:affiliation |
Department of Nephrology, Pitié-Salpêtrière Hospital, Paris, France.
|
|
pubmed:publicationType |
Journal Article
|
